Supplementary Appendix

Similar documents
Quality ID #343: Screening Colonoscopy Adenoma Detection Rate National Quality Strategy Domain: Effective Clinical Care

Alberta Colorectal Cancer Screening Program (ACRCSP) Post Polypectomy Surveillance Guidelines

Research Article Development of Polyps and Cancer in Patients with a Negative Colonoscopy: A Follow-Up Study of More Than 20 Years

removal of adenomatous polyps detects important effectively as follow-up colonoscopy after both constitute a low-risk Patients with 1 or 2

This is the portion of the intestine which lies between the small intestine and the outlet (Anus).

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Outcome High Priority

Carol A. Burke, MD, FACG

6 semanas de embarazo. Tubulovillous adenoma with dysplasia icd 10. Inicio / Embarazo / 6 semanas de embarazo

EXPERT WORKING GROUP Surveillance after neoplasia removal. Meeting Chicago, May 5th 2017 Chair: Rodrigo Jover Uri Ladabaum

Polyp detection rates as quality indicator in clinical versus screening colonoscopy

Measure #343: Screening Colonoscopy Adenoma Detection Rate National Quality Strategy Domain: Effective Clincal Care

Is the level of cleanliness using segmental Boston bowel preparation scale associated with a higher adenoma detection rate?

WEO CRC SC Meeting. Barcelona, Spain October 23, 2015

Supplementary Online Content

General and Colonoscopy Data Collection Form

Table S2 Study group sample sizes for CEA, CYFRA21-1 and CA125 determinations.

Colon and Rectum. Protocol revision date: January 2005 Based on AJCC/UICC TNM, 6th edition

Variation in Detection of Adenomas and Polyps by Colonoscopy and Change Over Time With a Performance Improvement Program

Polyps Adenomas Lipomas

Quality of and compliance with colonoscopy in Lynch Syndrome surveillance: are we getting it right?

Pathology in Slovenian CRC screening programme: Organisation and quality assurance. Snježana Frković Grazio and Matej Bračko

Colorectal Cancer Screening: Colonoscopy, Potential and Pitfalls. Disclosures: None. CRC: still a major public health problem

Missed Lesions at Endoscopy. Dr Russell Walmsley, MD, FRCP, FRACP Gastroenterologist WDHB Chair Endoscopy Guidance Group for New Zealand

Pathology in Slovenian CRC screening programme:

DIGESTIVE SYSTEM SURGICAL PROCEDURES May 1, 2015 INTESTINES (EXCEPT RECTUM) Asst Surg Anae

Guidelines for Colonoscopy Surveillance After Screening and Polypectomy: A Consensus Update by the US Multi-Society Task Force on Colorectal Cancer

Advanced colon cancer icd 10

GI Coding Updates. Rhonda Buckholtz, CPC, CPCI, CPMS, CRC, CDEO, CHPSE, CGSC, COBGC, CENTC, CPEDC

Incidence and Multiplicities of Adenomatous Polyps in TNM Stage I Colorectal Cancer in Korea

Predict, Resect and discard : Yes we can! (at least in some hands)

Colorectal cancer is the second leading cause of cancer-related. Colonoscopic Miss Rates for Right-Sided Colon Cancer: A Population-Based Analysis

Sessile Serrated Polyps

How to characterize dysplastic lesions in IBD?

Supplemental Digital Content 1. Endoscopic and histolological findings in INR and FR study subjects

Post-polypectomy follow-up after. removal of colorectal neoplasia

Improving the quality of endoscopic polypectomy by introducing a colonoscopy quality assurance program

General Session 7: Controversies in Screening and Surveillance in Colorectal Cancer

Dysplasia 4/19/2017. How do I practice Chromoendoscopy for Surveillance of Colitis? SCENIC: Polypoid Dysplasia in UC. Background

Colon Cancer Screening. Layth Al-Jashaami, MD GI Fellow, PGY 4

Monitoring of colonoscopy quality indicators in an academic endoscopy facility reveals adherence to international recommendations

Is there justification for levels of polyp competency? Dr Roland Valori Gloucestershire Hospitals United Kingdom

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

Endocuff assisted colonoscopy significantly increases sessile serrated adenoma detection in veterans

Colorectal cancer: colonoscopic surveillance for prevention of colorectal cancer in patients with ulcerative colitis, Crohn s disease and polyps

Original Article ABSTRACT BACKGROUND

Supporting Information 2. ESGE QIC Lower GI Delphi voting process: Round 1 Working Group chair: Michal F. Kaminski, Poland

Purpose. Encourage standard exchange of data between two key public health partners

AMERICAN GASTROENTEROLOGICAL ASSOCIATION DIGESTIVE HEALTH RECOGNITION PROGRAM IN COLLABORATION WITH CECITY. Non-PQRS Narrative Measure Specifications

CEA (CARCINOEMBRYONIC ANTIGEN)

Page 1. Is the Risk This High? Dysplasia in the IBD Patient. Dysplasia in the Non IBD Patient. Increased Risk of CRC in Ulcerative Colitis

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Kenneth D. Chi, MD Medical Director, GI Lab Advocate Lutheran General Hospital Center for Digestive Health May 7, 2016

Early detection and screening for colorectal neoplasia

Clinicopathological features of colorectal polyps in 2002 and 2012

COLORECTAL CANCER FAISALGHANISIDDIQUI MBBS; FCPS; PGDIP-BIOETHICS; MCPS-HPE

A916: rectum: adenocarcinoma

COLORECTAL CANCER SCREENING

Retroflexion and prevention of right-sided colon cancer following colonoscopy: How I approach it

Screening & Surveillance Guidelines

Measure #425: Photodocumentation of Cecal Intubation National Quality Strategy Domain: Effective Clinical Care

8. The polyp in the illustration can be described as (circle all that apply) a. Exophytic b. Pedunculated c. Sessile d. Frank

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

Douglas K. Rex, MD Indiana University Hospital Indianapolis, IN

Razvan I. Arsenescu, MD Assistant Professor of Medicine Division of Digestive Diseases EARLY DETECTION OF COLORECTAL CANCER

Measure Description. Denominator Statement

GIQIC18 Appropriate follow-up interval of not less than 5 years for colonoscopies with findings of 1-2 tubular adenomas < 10 mm

Neoplastic Colon Polyps. Joyce Au SUNY Downstate Grand Rounds, October 18, 2012

Carcinoembryonic Antigen

2017 OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS ONLY. MEASURE TYPE: Process

The Importance of Complete Colonoscopy and Exploration of the Cecal Region

Risk Factors for Incomplete Polyp Resection during Colonoscopic Polypectomy

Performance measures for lower gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative

Quality indicators for colonoscopy and colonoscopist. Mirjana Kalauz Clinical Hospital Center Zagreb

EARLY DETECTION OF COLORECTAL CANCER. Epidemiology of CRC

Variable Endoscopist performance in proximal and distal adenoma detection during colonoscopy: a retrospective cohort study

Measure #425: Photodocumentation of Cecal Intubation National Quality Strategy Domain: Effective Clinical Care

Imaging Evaluation of Polyps. CT Colonography: Sessile Adenoma. Polyps, DALMs & Megacolon Objectives

Interval Cancers: What is Next?

When is a programmed follow-up meaningful and how should it be done? Professor Alastair Watson University of Liverpool

Title Description Type / Priority

The Prevalence Rate and Anatomic Location of Colorectal Adenoma and Cancer Detected by Colonoscopy in Average-Risk Individuals Aged Years

Adenoma detection rate in 41,010 patients from Southwest China

Follow up The way ahead. John Griffith

Hyperplastische Polyps Innocent bystanders?

Characteristics and outcomes of endoscopically resected colorectal cancers that arose from sessile serrated adenomas and traditional serrated adenomas

CRC and Dysplasia in IBD: Objectives of Talk. Colorectal Cancer and Dysplasia in IBD: A Case-Based Approach. Page 1

Two-stage optical system for colorectal polyp assessments

PROTOCOL FOR THE AUTHORIZATION AND AUDITING OF COLONOSCOPY CENTRES AND ENDOSCOPISTS

Colonoscopy Quality Data

DOES LOCATION MATTER IN COLORECTAL CANCER: LEFT VS RIGHT?

Colorectal Cancer Screening

Colorectal Cancer: Screening & Surveillance

Emerging Interventions in Endoscopy. Margaret Vance Nurse Consultant in Gastroenterology St Mark s Hospital

Colonoscopy MM /01/2010. PPO; HMO; QUEST Integration 10/01/2017 Section: Surgery Place(s) of Service: Outpatient

Quality in Endoscopy: Can We Do Better?

AS IN MANY COUNTRIES, INcluding

Colonic adenomas-a colonoscopy survey

Colorectal Cancer Screening and Surveillance

Patologia sistematica V Gastroenterologia Prof. Stefano Fiorucci. Colon polyps. Colorectal cancer

Transcription:

Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Kaminski MF, Regula J, Kraszewska E, et al. Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med 2010;362:1795-803.

Supplementary Table 1. Characteristics of interval colorectal cancers and affected individuals. Case No* Sex Age - Family history of CRC Screening colonoscopy findingsp Extent of examination Interval CRC localization Interval CRC pathology; ICD-O Time from screening endoscopy - Scheduled time of surveillance - 1 M 55 None Normal Complete Sigmoid colon 82113 0.5 10 2 F 57 None Normal Complete Cecum 81403 0.6 10 3 M 62 None ATV, HGD, < 10mm, Rectum, Complete removal Complete Colon, not specified 82113 0.6 3 4 F 57 None Diverticuli, Sigmoid colon Complete Cecum 82303 0.8 10 5 F 59 None HP, Sigmoid colon Complete Sigmoid colon 81403 0.9 10 6 F 63 None Normal Complete Rectum 81403 1.0 10 7 F 61 None Normal Complete Sigmoid colon 82113 1.0 10 8 F 56 None Normal Complete Recto-sigmoid junction 81403 1.2 10 9 M 51 None ATV, LGD, <10mm, Descending colon; Complete Rectum 81403 1.2 3

Two AT, LGD, <10mm, Sigmoid colon; ATV, LGD, 10mm, Rectum, Completeness of removal not assessed 10 M 62 None Normal Complete Descending colon 81403 1.5 10 11 M 59 None Normal Complete Rectum 81403 1.5 10 12 F 52 None Normal Complete Sigmoid colon 81403 1.5 10 13 F 53 None Normal Complete Sigmoid colon 82113 1.6 10 14 M 63 None Normal 15 F 53 None Normal Incomplete; Transverse Incomplete; Ascending Rectum 81403 1.8 5 Rectum 82113 1.9 5 16 F 52 None Normal Complete Hepatic flexure 81403 1.9 10 17 F 51 None Normal Complete Colon, not specified 81403 2.1 10 18 F 65 None Diverticuli, Sigmoid colon Incomplete; Splenic flexure Rectum 81403 2.1 5 19 F 65 None Polyp, <5mm, not retrieved, Complete Rectum 81403 2.2 10

Ascending colon 20 F 61 None Normal Complete Sigmoid colon 81403 2.2 10 21 M 65 None Normal Complete Rectum 81403 2.4 10 22 F 61 None HP, Sigmoid colon Complete Sigmoid colon 81403 2.5 10 23 F 62 None Diverticuli, Descending colon Complete Rectum 84803 2.5 10 24 F 52 None Normal Complete Cecum 84803 2.6 10 25 M 58 relative >60 Two AT, LGD <5mm, Ascending colon, Rectum, Complete removal Complete Hepatic flexure 81403 2.7 5 26 M 53 None Diverticuli Sigmoid colon Complete Not specified 81403 2.7 10 27 M 51 None Two polyps, < 5mm, not retrieved, Rectum Complete Hepatic flexure 82113 2.7 10 28 F 63 relative >60 Normal Complete Colon, not specified 82113 2.8 5 29 M 50 relative <60 Diverticuli Sigmoid colon Complete Ascending colon 81403 2.9 5

30 F 64 None 31 M 53 None Diverticuli, Sigmoid colon Diverticuli, Sigmoid colon Complete Hepatic flexure 81403 3.1 10 Complete Rectum 82113 3.2 10 Incomplete, 32 F 60 relative <60 Normal Descending/ Rectum 81403 3.3 5 Sigmoid 33 F 64 None Non specific colitis, Sigmoid colon Complete Sigmoid colon 84803 3.4 10 34 F 65 None Normal Complete Cecum 81403 4.1 10 35 M 53 None Normal Complete Sigmoid colon 82113 4.4 10 36 M 62 None Normal Incomplete; Transverse Rectum 81403 4.4 5 37 M 46 None Normal Complete Ascending colon 81403 4.4 10 38 M 62 relative >60 Diverticuli, Descending colon Complete Rectum 81403 4.4 5 39 F 55 relative <60 Normal Complete Rectum 81403 4.4 5 40 F 55 None Normal Complete Rectum 82113 4.5 10

41 F 59 relative >60 HP, Sigmoid colon and rectum Complete Not specified 84803 4.7 5 42 M 66 None Normal Complete Ascending colon 81403 4.7 10 *Cases are listed in the order of increasing time from screening colonoscopy. Age at screening examination. Following abbreviations were used for the endoscopy findings: AT tubular adenoma, ATV tubulovillous adenoma, HP hyperplastic polyp, LGD low grade dysplasia, HGD high grade dysplasia. 82113 tubular adenocarcinoma; 81403 adenocarcinoma, not otherwise specified; 84803 mucinous adenocarcinoma; 82303 solid carcinoma, not otherwise specified 17 With normal endoscopy findings screening at 5 years was indicated when examination was limited to the left colon. Patient with no family history of colorectal cancer (CRC), but screened below the age of 50 years.

Supplementary Table 2. Risk factors for interval colorectal cancer occurrence in the secondary analysis population* Covariates in the model for interval cancer Number of Number of P value Hazard Ratio P value occurrence participants interval cancers (LR test) [95% CI] Screenee s age <0.001 40 49 6,981 1 1 50 54 15,649 13 6.91 [0.87, 55.22] 0.07 55 59 13,777 11 6.84 [0.84, 55.59] 0.07 60 66 12,551 23 15.72 [2.02, 122.63] 0.009 Screenee s family history of CRC 0.78 No family history 38,698 40 Two first-degree relatives with CRC 444 1 One first-degree relative <60 of age with CRC 2,615 2

One first-degree relative 60 of age with CRC 7,201 5 Sex of screene 0.55 Female 31,490 29 Male 17,468 19 Endoscopist s adjusted cecal intubation rate 0.45 <85% 7,358 9 85% 89.9% 7,210 11 90% 92.9% 7,824 8 93% 94.9% 4,313 2 95% 100% 22,253 18 Endoscopist s adenoma detection rate 0.06

20% 10,716 4 1 15% 19.9% 7,080 7 3.81 [1.08, 13.45] 0.04 11% 14.9% 13,920 14 3.86 [1.20, 12.39] 0.02 <11% 17,242 23 3.43 [1.05, 11.24] 0.04 Age of endoscopist 0.05 39 18,958 13 1 40 49 24,989 24 1.65 [0.80, 3.40] 0.17 50 5,011 11 3.26 [1.29, 8.24] 0.01 Sex of endoscopist 0.08 Female 8,454 12 Male 40,504 36

Specialization of endoscopists 0.72 Gastroenterology Internal medicine or no specialty Surgery (any kind) 18,632 14,220 16,106 17 14 17 * The secondary analysis did not exclude participants with inadequate bowel preparation. Moreover, interval cancer was re-defined to include cancers occurring in bowel segments that were not evaluated during the screening colonoscopy. The secondary analysis population consisted of 48,958 participants followed in cancer registers for a median of 52.3 months (interquartile range, 41.4 to 60.0 months) for the occurrence of interval cancer. Over the follow-up period of 205,745 person years, a total of 48 interval colorectal cancers were identified. Of the six additional interval cancers as compared to primary population analysis, two occurred in participants with inadequately prepared colons and four in participants with incomplete examinations. The likelihood ratio test for models with and without the specified covariate Although significant at a border level, we decided to present the hazard ratio, because the factor was significant in the primary analysis